HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Differential Spatial Distribution of TSPO or Amino Acid PET Signal and MRI Contrast Enhancement in Gliomas.

Abstract
In this study, dual PET and contrast enhanced MRI were combined to investigate their correlation per voxel in patients at initial diagnosis with suspected glioblastoma. Correlation with contrast enhancement (CE) as an indicator of BBB leakage was further used to evaluate whether PET signal is likely caused by BBB disruption alone, or rather attributable to specific binding after BBB passage. PET images with [18F]GE180 and the amino acid [18F]FET were acquired and normalized to healthy background (tumor-to-background ratio, TBR). Contrast enhanced images were normalized voxel by voxel with the pre-contrast T1-weighted MRI to generate relative CE values (rCE). Voxel-wise analysis revealed a high PET signal even within the sub-volumes without detectable CE. No to moderate correlation of rCE with TBR voxel-values and a small overlap as well as a larger distance of the hotspots delineated in rCE and TBR-PET images were detected. In contrast, voxel-wise correlation between both PET modalities was strong for most patients and hotspots showed a moderate overlap and distance. The high PET signal in tumor sub-volumes without CE observed in voxel-wise analysis as well as the discordant hotspots emphasize the specificity of the PET signals and the relevance of combined differential information from dual PET and MRI images.
AuthorsLena Kaiser, Adrien Holzgreve, Stefanie Quach, Michael Ingrisch, Marcus Unterrainer, Franziska J Dekorsy, Simon Lindner, Viktoria Ruf, Julia Brosch-Lenz, Astrid Delker, Guido Böning, Bogdana Suchorska, Maximilian Niyazi, Christian H Wetzel, Markus J Riemenschneider, Sophia Stöcklein, Matthias Brendel, Rainer Rupprecht, Niklas Thon, Louisa von Baumgarten, Jörg-Christian Tonn, Peter Bartenstein, Sibylle Ziegler, Nathalie L Albert
JournalCancers (Cancers (Basel)) Vol. 14 Issue 1 (Dec 23 2021) ISSN: 2072-6694 [Print] Switzerland
PMID35008218 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: